VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study compares the efficacy and safety of intravenous (IV) iron (VIT45) versus oral iron
(ferrous sulfate) administered to subjects who suffer from anemia and are diagnosed with
non-dialysis dependent chronic kidney disease (NDD-CKD).